glutamine has been researched along with lorglumide in 30 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 24 (80.00) | 18.7374 |
1990's | 6 (20.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Baba, S; Fujii, M; Fujisawa, T; Hasegawa, H; Koide, M; Nakamura, T; Okabayashi, Y; Otsuki, M; Tani, S | 1 |
Nagy, I; Pap, A; Takács, T; Varró, V | 1 |
Douglas, BR; Jansen, JB; Lamers, CB; Rovati, LC; Woutersen, RA | 1 |
Hashimoto, T; MacLellan, DG; Poston, GJ; Thompson, JC; Townsend, CM; Upp, JR | 1 |
Kellstein, DE; Mayer, DJ | 1 |
Bastié, MJ; Pradayrol, L; Scemama, JL; Seva, C; Vaysse, N | 1 |
Iwamoto, Y; Kuzuya, T; Yamamoto, R | 1 |
Grendell, JH; Liddle, RA; Niederau, C; Williams, JA | 1 |
Dobronyi, I; Papp, M; Scarpignato, C; Varga, G | 1 |
Chang, JH; Moriyoshi, Y; Shimizu, K; Shiratori, K; Takeuchi, T; Watanabe, S | 1 |
Papp, M; Scarpignato, C; Varga, G | 1 |
Abe, M; Funakoshi, A; Shinozaki, H; Wakasugi, H | 1 |
Baba, S; Inui, A; Sakatani, N | 1 |
Dembinski, A; Jaworek, J; Konturek, PK; Konturek, SJ; Warzecha, Z | 1 |
Ahrén, B; Karlsson, S | 1 |
Burt, S; Kerwin, JF; Kopecka, H; Lin, CW; Miller, T; Nadzan, AM; Witte, D | 1 |
de Jong, AJ; Douglas, BR; Jansen, JB; Lamers, CB; Rovati, LC; Woutersen, RA | 2 |
de Jong, AJ; Jansen, JB; Lamers, CB | 1 |
Konturek, P; Konturek, SJ; Laskiewicz, J; Thor, P | 1 |
Jiang, LH; Kasser, RJ; Wang, RY | 1 |
Funakoshi, A; Kitani, K; Miyasaka, K; Nakamura, R | 1 |
Baba, S; Inoue, T; Inui, A; Morioka, H; Oya, M; Sakatani, N | 2 |
Cieszkowski, M; Hladij, M; Konturek, SJ; Szewczyk, K; Tasler, J | 1 |
Bani, M; Cereda, R; Chisté, R; Makovec, F; Pacini, MA; Revel, L; Rovati, LA; Rovati, LC; Setnikar, I | 1 |
Bani, M; Chistè, R; Makovec, F; Revel, L; Rovati, LC; Setnikar, I | 1 |
Bani, M; Cereda, R; Chistè, R; Makovec, F; Pacini, MA; Revel, L; Rovati, LC | 1 |
Barthó, L; Holzer, P; Lembeck, F; Lippe, IT; Setnikar, I | 1 |
Bareggi, SR; Bianchi, M; Mantegazza, P; Panerai, AE; Rovati, LC | 1 |
30 other study(ies) available for glutamine and lorglumide
Article | Year |
---|---|
Proglumide analogues CR 1409 and CR 1392 inhibit cholecystokinin-stimulated insulin release more potently than exocrine secretion from the isolated perfused rat pancreas.
Topics: Animals; Cholecystokinin; Glutamine; In Vitro Techniques; Insulin; Insulin Secretion; Islets of Langerhans; Male; Pancreas; Proglumide; Radioimmunoassay; Rats; Rats, Inbred Strains | 1990 |
The effect of CR 1409, a potent CCK receptor antagonist, on basal and stimulated pancreatic secretion in rat.
Topics: Animals; Bicarbonates; Dose-Response Relationship, Drug; Glutamine; Male; Pancreas; Pancreatic Juice; Proglumide; Rats; Rats, Inbred Strains; Receptors, Cholecystokinin; Secretory Rate; Sincalide | 1990 |
Comparison of the effect of lorglumide on pancreatic growth stimulated by camostate in rat and hamster.
Topics: Animals; Cholecystokinin; Cricetinae; DNA; Esters; Gabexate; Gelatin; Glutamine; Guanidines; Male; Mesocricetus; Organ Size; Pancreas; Proglumide; Proteins; Rats; Rats, Inbred Strains; Stimulation, Chemical; Trypsin Inhibitors | 1990 |
In vivo comparison of inhibition with proglumide and CR-1409 of cholecystokinin-induced pressure in the biliary tract of the guinea pig.
Topics: Animals; Cholecystokinin; Dose-Response Relationship, Drug; Gallbladder; Glutamine; Guinea Pigs; Male; Muscle Contraction; Pressure; Proglumide; Time Factors; Transducers | 1990 |
Chronic administration of cholecystokinin antagonists reverses the enhancement of spinal morphine analgesia induced by acute pretreatment.
Topics: Analgesia; Animals; Cholecystokinin; Glutamine; Injections, Spinal; Male; Morphine; Proglumide; Rats; Rats, Inbred Strains; Spinal Cord | 1990 |
Lorglumide and loxiglumide inhibit gastrin-stimulated DNA synthesis in a rat tumoral acinar pancreatic cell line (AR42J).
Topics: Animals; DNA, Neoplasm; Gastrins; Glutamine; Ornithine Decarboxylase; Pancreatic Neoplasms; Proglumide; Rats; Receptors, Cholecystokinin; Thymidine; Tumor Cells, Cultured | 1990 |
CR-1409: a potent inhibitor of cholecystokinin-stimulated amylase release and cholecystokinin binding in rat pancreatic acini.
Topics: Amylases; Animals; Dose-Response Relationship, Drug; Glutamine; Male; N-Methylscopolamine; Pancreas; Proglumide; Rats; Rats, Inbred Strains; Receptors, Cholecystokinin; Scopolamine Derivatives; Sincalide | 1987 |
Pancreatic growth: interaction of exogenous cholecystokinin, a protease inhibitor, and a cholecystokinin receptor antagonist in mice.
Topics: Amylases; Animals; Cholecystokinin; Chymotrypsinogen; Esters; Gabexate; Glutamine; Guanidines; Male; Mice; Organ Size; Pancreas; Proglumide; Protease Inhibitors; Sincalide | 1987 |
Effect of a new potent CCK antagonist, lorglumide, on caerulein- and bombesin-induced pancreatic secretion and growth in the rat.
Topics: Amylases; Anesthesia; Animals; Body Weight; Bombesin; Ceruletide; Cholecystokinin; DNA; Glutamine; In Vitro Techniques; Male; Pancreas; Proglumide; Rats; Rats, Inbred Strains; Trypsin | 1989 |
[Inhibitory effect of CR 1409 (cholecystokinin antagonist) on pancreatic exocrine secretion in rats].
Topics: Amylases; Animals; Cholecystokinin; Glutamine; Male; Pancreas; Pancreatic Juice; Proglumide; Rats; Rats, Inbred Strains; Sincalide | 1989 |
Pancreatic secretory and trophic response to caerulein in rats: effect of proglumide and lorglumide.
Topics: Amylases; Animals; Body Weight; Ceruletide; DNA; Glutamine; In Vitro Techniques; Organ Size; Pancreas; Pancreatic Juice; Proglumide; Proteins; Rats; Rats, Inbred Strains; Receptors, Cholecystokinin; Trypsin | 1989 |
The inhibitory effect of CR-1409 on amylase secretion and intracellular Ca2+ mobilization in rat pancreatic acini in vitro.
Topics: Amylases; Animals; Benzofurans; Calcium; Carbachol; Ceruletide; Cytoplasm; Fluorescent Dyes; Fura-2; Gastrin-Releasing Peptide; Glutamine; In Vitro Techniques; Male; Pancreas; Peptides; Perfusion; Proglumide; Rats; Rats, Inbred Strains; Spectrometry, Fluorescence | 1989 |
[The effect of cholecystokinin antagonists on satiety induced by cholecystokinin octapeptide in dogs].
Topics: Animals; Blood-Brain Barrier; Cholecystokinin; Dogs; Eating; Glutamine; Injections, Intravenous; Injections, Intraventricular; Proglumide; Receptors, Cholecystokinin; Sincalide | 1989 |
Cholecystokinin receptor antagonism by peptidergic and non-peptidergic agents in rat pancreas.
Topics: Animals; Benzodiazepinones; Bombesin; Ceruletide; Cholecystokinin; Devazepide; DNA; Esters; Gabexate; Glutamine; Guanidines; Pancreas; Pentagastrin; Proglumide; Protease Inhibitors; Proteins; Rats; Receptors, Cholecystokinin | 1989 |
Effects of three different cholecystokinin receptor antagonists on basal and stimulated insulin and glucagon secretion in mice.
Topics: Animals; Benzodiazepinones; Blood Glucose; Devazepide; Female; Glucagon; Glutamine; Insulin; Insulin Secretion; Islets of Langerhans; Mice; Mice, Inbred Strains; Proglumide; Receptors, Cholecystokinin | 1989 |
Hybrid cholecystokinin (CCK) antagonists: new implications in the design and modification of CCK antagonists.
Topics: Benzodiazepines; Benzodiazepinones; Chemical Phenomena; Chemistry; Cholecystokinin; Devazepide; Drug Design; Glutamine; Molecular Conformation; Proglumide; Receptors, Cholecystokinin; Stereoisomerism; Structure-Activity Relationship | 1989 |
Modulation by CR-1409 (lorglumide), a cholecystokinin receptor antagonist, of trypsin inhibitor-enhanced growth of azaserine-induced putative preneoplastic lesions in rat pancreas.
Topics: Animals; Azaserine; Cholecystokinin; Esters; Gabexate; Glutamine; Guanidines; Male; Pancreatic Neoplasms; Precancerous Conditions; Proglumide; Rats; Rats, Inbred Strains; Receptors, Cholecystokinin; Sincalide; Trypsin Inhibitors | 1989 |
Influence of cholecystokinin antagonist on the effects of cholecystokinin and bombesin on azaserine-induced lesions in rat pancreas.
Topics: Animals; Azaserine; Bombesin; Cholecystokinin; Glutamine; Male; Pancreas; Proglumide; Rats; Rats, Inbred Strains | 1989 |
The cholecystokinin receptor antagonist CR1409 increases plasma cholecystokinin in rats.
Topics: Animals; Cholecystokinin; Dose-Response Relationship, Drug; Glutamine; Male; Proglumide; Rats; Rats, Inbred Strains | 1989 |
Cholecystokinin in the regulation of intestinal motility and pancreatic secretion in dogs.
Topics: Animals; Benzodiazepinones; Bethanechol Compounds; Bicarbonates; Bombesin; Cholecystokinin; Devazepide; Dogs; Eating; Gastrins; Gastrointestinal Motility; Glutamine; Pancreatic Juice; Proglumide; Proteins; Reference Values | 1988 |
Cholecystokinin antagonist lorglumide reverses chronic haloperidol-induced effects on dopamine neurons.
Topics: Action Potentials; Animals; Dopamine; Glutamine; Haloperidol; Male; Nucleus Accumbens; Proglumide; Rats; Rats, Inbred Strains; Septal Nuclei; Sincalide; Substantia Nigra | 1988 |
Inhibitory effect of CR-1409, a competitive inhibitor of cholecystokinin, on pancreatic exocrine secretion in the conscious rat.
Topics: Animals; Bicarbonates; Cholecystokinin; Dose-Response Relationship, Drug; Female; Glutamine; Male; Pancreatic Juice; Proglumide; Proteins; Rats; Rats, Inbred Strains; Reference Values; Sincalide | 1988 |
Comparison of effects of proglumide and CR 1409, a new glutaramic acid derivative, on CCK-8-induced pancreatic polypeptide and insulin secretion in the dog.
Topics: Animals; Cholecystokinin; Dogs; Glutamine; Insulin; Insulin Secretion; Pancreatic Polypeptide; Proglumide | 1988 |
Effect of cholecystokinin receptor antagonist on pancreatic responses to exogenous gastrin and cholecystokinin and to meal stimuli.
Topics: Animals; Cholecystokinin; Dogs; Food; Gastric Fistula; Gastrins; Glutamine; Pancreas; Pancreatic Fistula; Pancreatic Polypeptide; Proglumide; Receptors, Cholecystokinin | 1988 |
Pharmacological properties of lorglumide as a member of a new class of cholecystokinin antagonists.
Topics: Animals; Cholecystokinin; Dogs; Gallbladder; Glutamine; Guinea Pigs; Ileum; In Vitro Techniques; Mice; Muscle Contraction; Pancreas; Proglumide; Rats; Receptors, Cholecystokinin | 1987 |
Different peripheral and central antagonistic activity of new glutaramic acid derivatives on satiety induced by cholecystokinin in rats.
Topics: Animals; Dose-Response Relationship, Drug; Glutamine; Male; Proglumide; Rats; Rats, Inbred Strains; Receptors, Cholecystokinin; Satiation; Sincalide | 1986 |
Antispasmodic activity on the gallbladder of the mouse of CR 1409 (lorglumide) a potent antagonist of peripheral CCK.
Topics: Animals; Atropine; Cholecystokinin; Dose-Response Relationship, Drug; Female; Gallbladder; Glutamine; Mice; Mice, Inbred Strains; Nifedipine; Papaverine; Parasympatholytics; Proglumide | 1987 |
Evaluation of a new and potent cholecystokinin antagonist on motor responses of the guinea-pig intestine.
Topics: Animals; Cholecystokinin; Dose-Response Relationship, Drug; Electric Stimulation; Female; Glutamine; Guinea Pigs; Ileum; In Vitro Techniques; Male; Muscle Contraction; Proglumide; Receptors, Cholecystokinin; Reflex | 1987 |
Proglumide has access to brain and antagonizes the central satiety effect of cholecystokinin octapeptide in the dog.
Topics: Animals; Blood-Brain Barrier; Brain; Dogs; Dose-Response Relationship, Drug; Drinking Behavior; Feeding Behavior; Glutamine; Infusions, Intravenous; Injections, Intraventricular; Proglumide; Satiation; Satiety Response; Sincalide; Time Factors | 1987 |
Effect of a cholecystokinin antagonist on some effects of diazepam.
Topics: Animals; Cholecystokinin; Diazepam; Dose-Response Relationship, Drug; Drug Synergism; Glutamine; Male; Mice; Mice, Inbred Strains; Motor Activity; Pentylenetetrazole; Proglumide; Seizures | 1987 |